Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genetic Testing | 24 | 2024 | 3530 | 1.700 |
Why?
|
Genetic Variation | 25 | 2023 | 6540 | 1.110 |
Why?
|
Sequence Analysis, DNA | 14 | 2020 | 4717 | 1.060 |
Why?
|
Genome, Human | 19 | 2024 | 4416 | 0.990 |
Why?
|
Genomics | 23 | 2023 | 5790 | 0.880 |
Why?
|
Computational Biology | 10 | 2022 | 3504 | 0.750 |
Why?
|
Pathology, Molecular | 4 | 2022 | 330 | 0.710 |
Why?
|
High-Throughput Nucleotide Sequencing | 13 | 2020 | 3618 | 0.690 |
Why?
|
Noonan Syndrome | 2 | 2017 | 120 | 0.650 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 3 | 2017 | 225 | 0.590 |
Why?
|
Leukemia, Myelomonocytic, Juvenile | 1 | 2017 | 25 | 0.560 |
Why?
|
Genetic Predisposition to Disease | 24 | 2024 | 17766 | 0.550 |
Why?
|
Databases, Genetic | 10 | 2021 | 1739 | 0.520 |
Why?
|
Software | 8 | 2020 | 4420 | 0.520 |
Why?
|
Information Dissemination | 5 | 2021 | 1132 | 0.500 |
Why?
|
Prion Diseases | 1 | 2016 | 98 | 0.480 |
Why?
|
Blood Group Antigens | 3 | 2022 | 187 | 0.480 |
Why?
|
GTP Phosphohydrolases | 2 | 2017 | 516 | 0.470 |
Why?
|
Prions | 1 | 2016 | 179 | 0.460 |
Why?
|
Cardiomyopathy, Hypertrophic | 6 | 2022 | 1300 | 0.450 |
Why?
|
Hyperlipoproteinemia Type II | 3 | 2024 | 396 | 0.430 |
Why?
|
Genetic Diseases, Inborn | 4 | 2020 | 601 | 0.410 |
Why?
|
Germ-Line Mutation | 3 | 2017 | 1843 | 0.400 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1791 | 0.400 |
Why?
|
Genome-Wide Association Study | 6 | 2024 | 12602 | 0.390 |
Why?
|
Genetic Counseling | 4 | 2024 | 625 | 0.350 |
Why?
|
Penetrance | 3 | 2023 | 388 | 0.350 |
Why?
|
Metamorphosis, Biological | 2 | 2009 | 37 | 0.350 |
Why?
|
Multifactorial Inheritance | 4 | 2024 | 1351 | 0.350 |
Why?
|
Disease | 3 | 2021 | 671 | 0.340 |
Why?
|
DNA Copy Number Variations | 2 | 2015 | 2008 | 0.340 |
Why?
|
Rh-Hr Blood-Group System | 2 | 2020 | 65 | 0.330 |
Why?
|
Sexual Development | 1 | 2009 | 40 | 0.320 |
Why?
|
Antigens, Human Platelet | 2 | 2019 | 41 | 0.320 |
Why?
|
Blood Grouping and Crossmatching | 2 | 2019 | 100 | 0.310 |
Why?
|
Mutation, Missense | 3 | 2019 | 2563 | 0.310 |
Why?
|
Algorithms | 7 | 2019 | 13967 | 0.300 |
Why?
|
Biological Specimen Banks | 4 | 2021 | 776 | 0.290 |
Why?
|
Laboratories | 3 | 2023 | 461 | 0.290 |
Why?
|
Hypercholesterolemia | 2 | 2024 | 1155 | 0.270 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2024 | 12281 | 0.270 |
Why?
|
Workflow | 3 | 2022 | 851 | 0.260 |
Why?
|
Drosophila melanogaster | 3 | 2010 | 1711 | 0.260 |
Why?
|
Neonatal Screening | 4 | 2024 | 595 | 0.250 |
Why?
|
Cardiomyopathies | 4 | 2020 | 1945 | 0.230 |
Why?
|
Genes, BRCA2 | 2 | 2017 | 604 | 0.230 |
Why?
|
BRCA2 Protein | 2 | 2019 | 797 | 0.230 |
Why?
|
Genes, BRCA1 | 2 | 2017 | 769 | 0.220 |
Why?
|
Vinculin | 2 | 2020 | 59 | 0.210 |
Why?
|
Humans | 77 | 2024 | 760261 | 0.200 |
Why?
|
BRCA1 Protein | 2 | 2019 | 1146 | 0.200 |
Why?
|
Alleles | 4 | 2023 | 6900 | 0.200 |
Why?
|
Pharmacogenetics | 3 | 2022 | 680 | 0.200 |
Why?
|
Quality Improvement | 1 | 2017 | 3840 | 0.200 |
Why?
|
Risk Assessment | 4 | 2023 | 24086 | 0.190 |
Why?
|
MNSs Blood-Group System | 1 | 2020 | 7 | 0.180 |
Why?
|
Heart Diseases | 1 | 2014 | 2809 | 0.180 |
Why?
|
Membrane Proteins | 2 | 2017 | 7854 | 0.180 |
Why?
|
Cardiomyopathy, Dilated | 3 | 2020 | 819 | 0.180 |
Why?
|
Genetics, Medical | 1 | 2023 | 336 | 0.180 |
Why?
|
Sexual Behavior, Animal | 2 | 2010 | 118 | 0.160 |
Why?
|
Genes, Insect | 2 | 2010 | 264 | 0.160 |
Why?
|
Biotinidase | 1 | 2018 | 17 | 0.160 |
Why?
|
RNA, Messenger | 1 | 2013 | 12762 | 0.160 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2019 | 761 | 0.150 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2016 | 3774 | 0.150 |
Why?
|
Canada | 3 | 2021 | 2128 | 0.150 |
Why?
|
Research Design | 3 | 2020 | 6181 | 0.150 |
Why?
|
Electronic Health Records | 5 | 2018 | 4763 | 0.140 |
Why?
|
Gene Expression Profiling | 2 | 2010 | 9388 | 0.130 |
Why?
|
Herpes Zoster | 1 | 2018 | 251 | 0.130 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2020 | 380 | 0.130 |
Why?
|
ABO Blood-Group System | 1 | 2018 | 369 | 0.130 |
Why?
|
Health | 1 | 2019 | 395 | 0.130 |
Why?
|
Primary Health Care | 3 | 2023 | 4649 | 0.130 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 1 | 2017 | 162 | 0.130 |
Why?
|
Infant, Newborn | 10 | 2024 | 26168 | 0.130 |
Why?
|
Government Programs | 1 | 2017 | 280 | 0.120 |
Why?
|
Guidelines as Topic | 2 | 2018 | 1395 | 0.120 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2024 | 15766 | 0.120 |
Why?
|
Exons | 1 | 2020 | 2391 | 0.120 |
Why?
|
ras Proteins | 1 | 2019 | 1051 | 0.110 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 2014 | 62 | 0.110 |
Why?
|
Male | 32 | 2024 | 359413 | 0.110 |
Why?
|
Medical History Taking | 1 | 2017 | 773 | 0.110 |
Why?
|
Mutation | 5 | 2021 | 29950 | 0.110 |
Why?
|
Skin Diseases, Genetic | 1 | 2014 | 49 | 0.110 |
Why?
|
Science | 1 | 2016 | 240 | 0.110 |
Why?
|
Erythrocytes | 2 | 2019 | 2415 | 0.110 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2014 | 152 | 0.100 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2014 | 93 | 0.100 |
Why?
|
Communicable Diseases | 1 | 2021 | 879 | 0.100 |
Why?
|
Gene Deletion | 1 | 2020 | 2668 | 0.100 |
Why?
|
Arthrogryposis | 1 | 2013 | 68 | 0.100 |
Why?
|
Female | 33 | 2024 | 391011 | 0.100 |
Why?
|
Genotype | 6 | 2023 | 12959 | 0.100 |
Why?
|
Risk Factors | 10 | 2024 | 74269 | 0.100 |
Why?
|
Data Interpretation, Statistical | 2 | 2019 | 2696 | 0.100 |
Why?
|
Marfan Syndrome | 1 | 2014 | 236 | 0.100 |
Why?
|
Chromosome Aberrations | 2 | 2021 | 1767 | 0.100 |
Why?
|
Decision Trees | 1 | 2013 | 506 | 0.100 |
Why?
|
Death, Sudden, Cardiac | 1 | 2019 | 1572 | 0.090 |
Why?
|
Comparative Genomic Hybridization | 1 | 2012 | 473 | 0.090 |
Why?
|
Chromosome Mapping | 4 | 2021 | 4625 | 0.090 |
Why?
|
Peer Review, Research | 1 | 2014 | 341 | 0.090 |
Why?
|
Rare Diseases | 1 | 2016 | 619 | 0.090 |
Why?
|
Polymorphism, Genetic | 1 | 2020 | 4286 | 0.080 |
Why?
|
Base Sequence | 3 | 2017 | 12447 | 0.080 |
Why?
|
Pupa | 1 | 2009 | 42 | 0.080 |
Why?
|
Pneumonia | 1 | 2021 | 2138 | 0.080 |
Why?
|
Receptors, Steroid | 1 | 2009 | 154 | 0.080 |
Why?
|
Arteries | 1 | 2014 | 1126 | 0.080 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2016 | 936 | 0.080 |
Why?
|
Coronary Disease | 1 | 2023 | 5993 | 0.080 |
Why?
|
Databases, Factual | 2 | 2021 | 8018 | 0.080 |
Why?
|
Genetic Association Studies | 4 | 2020 | 2716 | 0.080 |
Why?
|
Body Weight | 1 | 2019 | 4613 | 0.080 |
Why?
|
Vascular Malformations | 1 | 2014 | 464 | 0.080 |
Why?
|
Ion Channels | 1 | 2013 | 1043 | 0.080 |
Why?
|
Mechanotransduction, Cellular | 1 | 2013 | 530 | 0.070 |
Why?
|
Ultrasonography, Prenatal | 1 | 2016 | 1745 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2024 | 3524 | 0.070 |
Why?
|
Pedigree | 3 | 2020 | 4577 | 0.070 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2014 | 693 | 0.070 |
Why?
|
Middle Aged | 18 | 2024 | 220175 | 0.070 |
Why?
|
Larva | 1 | 2009 | 509 | 0.070 |
Why?
|
Cardiovascular Diseases | 2 | 2024 | 15740 | 0.070 |
Why?
|
Sepsis | 1 | 2021 | 2594 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2024 | 10340 | 0.070 |
Why?
|
Coronary Artery Disease | 2 | 2024 | 6661 | 0.070 |
Why?
|
Early Detection of Cancer | 2 | 2018 | 3215 | 0.070 |
Why?
|
Medical Informatics | 1 | 2013 | 733 | 0.070 |
Why?
|
Joint Instability | 1 | 2014 | 795 | 0.070 |
Why?
|
Adult | 17 | 2024 | 219847 | 0.070 |
Why?
|
RNA Splicing | 2 | 2022 | 914 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2021 | 20048 | 0.060 |
Why?
|
Bayes Theorem | 2 | 2024 | 2325 | 0.060 |
Why?
|
Phenotype | 5 | 2022 | 16543 | 0.060 |
Why?
|
Cohort Studies | 6 | 2024 | 41317 | 0.060 |
Why?
|
Decision Support Systems, Clinical | 1 | 2013 | 1162 | 0.060 |
Why?
|
Arrhythmias, Cardiac | 1 | 2014 | 2255 | 0.060 |
Why?
|
Epilepsy | 1 | 2019 | 3267 | 0.060 |
Why?
|
Gene Frequency | 2 | 2023 | 3605 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2022 | 5201 | 0.050 |
Why?
|
Health Surveys | 1 | 2013 | 4061 | 0.050 |
Why?
|
Prospective Studies | 3 | 2022 | 54263 | 0.050 |
Why?
|
Heterozygote | 2 | 2020 | 2797 | 0.050 |
Why?
|
Aging | 1 | 2021 | 8641 | 0.050 |
Why?
|
Duty to Recontact | 1 | 2021 | 19 | 0.050 |
Why?
|
Cluster Analysis | 1 | 2009 | 2698 | 0.050 |
Why?
|
Aged | 11 | 2024 | 168995 | 0.050 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2009 | 3601 | 0.050 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17628 | 0.050 |
Why?
|
Genetic Research | 1 | 2021 | 172 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 11341 | 0.040 |
Why?
|
Infant | 5 | 2024 | 36030 | 0.040 |
Why?
|
Biomedical Research | 1 | 2016 | 3421 | 0.040 |
Why?
|
Heart Defects, Congenital | 2 | 2014 | 4668 | 0.040 |
Why?
|
Drosophila Proteins | 1 | 2009 | 1699 | 0.040 |
Why?
|
Digestive System Diseases | 1 | 2021 | 151 | 0.040 |
Why?
|
North America | 1 | 2023 | 1282 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 1723 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2021 | 58947 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2009 | 2627 | 0.040 |
Why?
|
Urogenital Abnormalities | 1 | 2021 | 256 | 0.040 |
Why?
|
DNA | 2 | 2022 | 7236 | 0.040 |
Why?
|
Pregnancy | 2 | 2017 | 29725 | 0.040 |
Why?
|
Mosaicism | 1 | 2021 | 466 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 11835 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2020 | 22041 | 0.040 |
Why?
|
Galactosyltransferases | 1 | 2018 | 276 | 0.040 |
Why?
|
Pennsylvania | 1 | 2018 | 615 | 0.040 |
Why?
|
Obesity | 1 | 2019 | 12915 | 0.030 |
Why?
|
Chromosomes, Human | 1 | 2018 | 442 | 0.030 |
Why?
|
Young Adult | 5 | 2024 | 58673 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2009 | 4409 | 0.030 |
Why?
|
Neoplasms | 2 | 2017 | 22066 | 0.030 |
Why?
|
Gene Duplication | 1 | 2017 | 314 | 0.030 |
Why?
|
SOS1 Protein | 1 | 2016 | 40 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2021 | 612 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5793 | 0.030 |
Why?
|
Disclosure | 1 | 2021 | 738 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2016 | 266 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2016 | 203 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2018 | 939 | 0.030 |
Why?
|
Informed Consent | 1 | 2021 | 1007 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2020 | 21065 | 0.030 |
Why?
|
United States | 5 | 2023 | 72363 | 0.030 |
Why?
|
Counseling | 1 | 2023 | 1550 | 0.030 |
Why?
|
Virulence | 1 | 2018 | 1295 | 0.030 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2016 | 332 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2024 | 2422 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2017 | 582 | 0.030 |
Why?
|
Desmoplakins | 1 | 2014 | 62 | 0.030 |
Why?
|
Homozygote | 1 | 2018 | 1786 | 0.030 |
Why?
|
Adolescent | 5 | 2021 | 87747 | 0.030 |
Why?
|
Connective Tissue Diseases | 1 | 2016 | 286 | 0.030 |
Why?
|
Myopathies, Structural, Congenital | 1 | 2014 | 103 | 0.030 |
Why?
|
Child | 5 | 2021 | 79758 | 0.030 |
Why?
|
Sequence Analysis | 1 | 2013 | 240 | 0.030 |
Why?
|
Prognosis | 1 | 2013 | 29636 | 0.030 |
Why?
|
Carrier Proteins | 2 | 2017 | 4938 | 0.030 |
Why?
|
Financing, Organized | 1 | 2014 | 204 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 11902 | 0.030 |
Why?
|
Haplotypes | 1 | 2018 | 2764 | 0.030 |
Why?
|
Hypolipidemic Agents | 1 | 2016 | 626 | 0.020 |
Why?
|
Evidence-Based Practice | 1 | 2016 | 495 | 0.020 |
Why?
|
Age of Onset | 1 | 2019 | 3302 | 0.020 |
Why?
|
Drug Design | 1 | 2016 | 1062 | 0.020 |
Why?
|
Incidental Findings | 1 | 2016 | 698 | 0.020 |
Why?
|
Time Factors | 2 | 2010 | 40133 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2013 | 787 | 0.020 |
Why?
|
Transcription Factors | 1 | 2009 | 12100 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 2021 | 1899 | 0.020 |
Why?
|
Hearing Loss | 1 | 2016 | 780 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2015 | 1679 | 0.020 |
Why?
|
Dissection | 1 | 2010 | 298 | 0.020 |
Why?
|
Olfactory Receptor Neurons | 1 | 2009 | 96 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 14656 | 0.020 |
Why?
|
Family | 1 | 2019 | 3189 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1729 | 0.020 |
Why?
|
Insect Proteins | 1 | 2009 | 254 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9712 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4109 | 0.020 |
Why?
|
Blood Platelets | 1 | 2018 | 2522 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2052 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 1955 | 0.020 |
Why?
|
Health Behavior | 1 | 2017 | 2621 | 0.020 |
Why?
|
Lipids | 1 | 2016 | 3336 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12532 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2805 | 0.020 |
Why?
|
Child, Preschool | 2 | 2020 | 42034 | 0.020 |
Why?
|
Health Personnel | 1 | 2018 | 3310 | 0.010 |
Why?
|
Head | 1 | 2010 | 922 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2017 | 3598 | 0.010 |
Why?
|
Mass Screening | 1 | 2020 | 5422 | 0.010 |
Why?
|
Health Care Costs | 1 | 2017 | 3257 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8553 | 0.010 |
Why?
|
Brain | 1 | 2010 | 26912 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2017 | 3159 | 0.010 |
Why?
|
Animals | 3 | 2010 | 167940 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14482 | 0.010 |
Why?
|
Body Mass Index | 1 | 2019 | 12901 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15827 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2020 | 6855 | 0.010 |
Why?
|
Prevalence | 1 | 2017 | 15687 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2021 | 80301 | 0.010 |
Why?
|
Cell Line | 1 | 2013 | 15626 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 25928 | 0.010 |
Why?
|